Medical Devices Series C Investors & VC Firms
439 firms in this list, with a median first check of $1M. 92 of them lead rounds. Generated from verified public data and updated continuously.
OCV Partners
Los AngelesPre-Seed–Late Stage
5 people
SBI Investment
TokyoPre-Seed–Growth$2M – $227M
1 person
Truffle Capital
ParisSeed–Growth$5M – $15M
7 people
Clal Biotechnology Industries
Tel AvivSeed–Late Stage
9 people
Joy Capital
BeijingSeed–Growth
6 people
Shenzhen Capital Group
ShenzhenSeed–Growth$1.5M – $156M
3 people
Vesalius Biocapital III Partners SàRL
ConternSeed–Late Stage$10.8M
12 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
7 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
Vesalius Biocapital Partners
LuxembourgSeed–Late Stage$11M
5 people
Waarde Capital
CapellenPre-Seed–Late Stage$15M
5 people
Artiman Ventures
Palo AltoSeed–Late Stage$2M – $6M
10 people
HighCape Capital
WestportSeries C–Late Stage
7 people
Archetype Ventures
TokyoPre-Seed–Growth$875K – $92M
6 people
Ming capital
ShenzhenSeed–Late Stage
6 people
TusStar
BeijingPre-Seed–Growth
TVM Capital
MunichSeed–Late Stage$1.1M – $16.2M
6 people
Amzak Health
New YorkSeed–Late Stage
4 people
HBM Partners
ZugPre-Seed–Late Stage$5M – $50M
6 people
Launch Capital
TorontoPre-Seed–Growth
3 people
Kern Capital, LLC
LarkspurSeed–Late Stage$5M – $15M
1 person
Birch Venture Capital, Inc.
Taipei CitySeed–Late Stage
3 people
10x Group
MünchenSeed–Late Stage
6 people
IAG Capital Partners
CharlestonSeed–Late Stage
3 people
Related lists
Series C Investors & VC Firms (2842)Medical Devices Investors & VC Firms (1451)Series C Investors & VC Firms in North America (1414)Series C Investors & VC Firms in United States (1223)Medical Devices Seed Investors & VC Firms (1203)Medical Devices Series A Investors & VC Firms (1188)Series C Investors & VC Firms in Asia-Pacific (994)Series C Investors & VC Firms in Europe (960)Medical Devices Investors & VC Firms in North America (945)Series C Investors & VC Firms in Global (936)
Data sourced from public filings and firms' own websites — see our methodology.







































































